NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,625 | +0.9% | 2,755 | 0.0% | 0.03% | +14.3% |
| Q2 2023 | $278,008 | +9.7% | 2,755 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $253,460 | +1.1% | 2,755 | -0.3% | 0.03% | -9.7% |
| Q4 2022 | $250,659 | +19.4% | 2,763 | 0.0% | 0.03% | +14.8% |
| Q3 2022 | $210,000 | -10.3% | 2,763 | 0.0% | 0.03% | -6.9% |
| Q2 2022 | $234,000 | -3.3% | 2,763 | 0.0% | 0.03% | -3.3% |
| Q1 2022 | $242,000 | 0.0% | 2,763 | 0.0% | 0.03% | +3.4% |
| Q4 2021 | $242,000 | +7.1% | 2,763 | 0.0% | 0.03% | -3.3% |
| Q3 2021 | $226,000 | -10.3% | 2,763 | 0.0% | 0.03% | -11.8% |
| Q2 2021 | $252,000 | -86.2% | 2,763 | -87.1% | 0.03% | -87.7% |
| Q1 2021 | $1,829,000 | -20.6% | 21,393 | -12.3% | 0.28% | -24.8% |
| Q4 2020 | $2,304,000 | +9.3% | 24,403 | +0.7% | 0.37% | -4.7% |
| Q3 2020 | $2,108,000 | -24.1% | 24,243 | -23.8% | 0.38% | -31.5% |
| Q2 2020 | $2,777,000 | +5.6% | 31,797 | -0.3% | 0.56% | -10.4% |
| Q1 2020 | $2,629,000 | -14.9% | 31,892 | -2.3% | 0.63% | +1.1% |
| Q4 2019 | $3,090,000 | +13.0% | 32,637 | +3.7% | 0.62% | -6.9% |
| Q3 2019 | $2,735,000 | -7.0% | 31,478 | -2.2% | 0.67% | -4.6% |
| Q2 2019 | $2,940,000 | -9.4% | 32,202 | -4.6% | 0.70% | -23.2% |
| Q1 2019 | $3,246,000 | +13.4% | 33,762 | +1.2% | 0.91% | +5.8% |
| Q4 2018 | $2,862,000 | -0.9% | 33,358 | -0.5% | 0.86% | +18.2% |
| Q3 2018 | $2,888,000 | +100.4% | 33,518 | +75.7% | 0.73% | +51.5% |
| Q2 2018 | $1,441,000 | -18.4% | 19,073 | -12.7% | 0.48% | -19.2% |
| Q1 2018 | $1,767,000 | -32.0% | 21,852 | -29.4% | 0.59% | -27.9% |
| Q4 2017 | $2,598,000 | -2.1% | 30,944 | +0.1% | 0.82% | -4.4% |
| Q3 2017 | $2,654,000 | +4.6% | 30,909 | +1.7% | 0.86% | +0.2% |
| Q2 2017 | $2,537,000 | +14.2% | 30,389 | +1.6% | 0.86% | +10.8% |
| Q1 2017 | $2,222,000 | +9.1% | 29,919 | +7.0% | 0.78% | +6.9% |
| Q4 2016 | $2,037,000 | -13.8% | 27,959 | -6.6% | 0.73% | -14.7% |
| Q3 2016 | $2,363,000 | -4.7% | 29,925 | -0.4% | 0.85% | -7.0% |
| Q2 2016 | $2,480,000 | -99.9% | 30,060 | +11.5% | 0.92% | +18.4% |
| Q1 2016 | $1,952,982,000 | +93793.4% | 26,960 | +11.5% | 0.77% | -12.1% |
| Q4 2015 | $2,080,000 | – | 24,175 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |